Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02866747 |
|---|---|
| Brief Title: | A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma (STERIMGLI) |
| First Submitted : | August 5, 2016 |
| First Submitted that Met QC Criteria : | August 10, 2016 |
| First Posted : | August 15, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | March 25, 2022 |
| Last Update Posted : | March 28, 2022 |